![]() Rodin Therapeutics Rodin Therapeutics is discovering and developing first in class therapeutics for neurological disorders, applying unique insights into the role of epigenetics and novel chemical strategies to target specific HDAC complexes. | ![]() UCB UCB is a company that provides biopharmaceutical research and development solutions for neurological and immunological conditions. | ![]() Genentech Genentech is a biotechnology company that discovers, develops, manufactures, and commercializes medicines. | ![]() Cipla Cipla is a pharmaceutical company focused on the development, manufacturing, and distribution of medications and healthcare products. | Livzon Pharmaceutical Group Livzon Pharmaceutical Group (丽珠医药集团股份有限公司, 丽珠医药) is a pharmaceutical company that engages in the development and production of active pharmaceutical ingredients, biological drugs, diagnostic reagents, and other products. | |
Founding Date | Founding Date 2013 | Founding Date 1928 | Founding Date 1976 | Founding Date 1935 | Founding Date 1985 |
Type | Type Subsidiary | Type Public | Type Subsidiary | Type Public | Type Public |
Tags | |||||
Locations | Locations Boston, US HQ | Locations Brussels, BE HQ Melbourne, AU Vienna, AT Braine L'alleud, BE Braine L'alleud, BE Leuven, BE São Paulo, BR see more | Locations South San Francisco, US HQ Hillsboro, US Oceanside, US Portland, US South San Francisco, US South San Francisco, US South San Francisco, US see more | Locations Mumbai, IN HQ Melbourne, AU Antwerpen, BE São Paulo, BR São Paulo, BR Unterhaching, DE Nairobi, KE see more | Locations Zhuhai, CN HQ Chengdu, CN Qingyuan, CN Shanghai, CN Shaoguan, CN Shenzhen, CN Zhuhai, CN |
Employees | Employees 1 | Employees 9,052 | Employees 18,077 | Employees 27,764 | Employees 9,067 |
Valuation ($) | Valuation ($) N/A | Valuation ($) 34.3 b | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 4.2 b |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) €7.4b (FY, 2025) | Revenue (est.) N/A | Revenue (est.) ₹277.1b (FY, 2026) | Revenue (est.) ¥11.7b (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods €1.4b (FY, 2025) | Cost of goods N/A | Cost of goods ₹97.2b (FY, 2026) | Cost of goods ¥4.1b (FY, 2025) |
Gross profit | Gross profit N/A | Gross profit €7.2b (FY, 2025) | Gross profit N/A | Gross profit ₹184.4b (FY, 2026) | Gross profit ¥7.8b (FY, 2025) |
Net income | Net income N/A | Net income €1.6b (FY, 2025) | Net income N/A | Net income ₹38.7b (FY, 2026) | Net income ¥2.4b (FY, 2025) |

UCB is a company that provides biopharmaceutical research and development solutions for neurological and immunological conditions.
View company
Genentech is a biotechnology company that discovers, develops, manufactures, and commercializes medicines.
View company
Cipla is a pharmaceutical company focused on the development, manufacturing, and distribution of medications and healthcare products.
View companyLivzon Pharmaceutical Group (丽珠医药集团股份有限公司, 丽珠医药) is a pharmaceutical company that engages in the development and production of active pharmaceutical ingredients, biological drugs, diagnostic reagents, and other products.
View company